SR-13179

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSR-13179
Drug Alias NameSR-13179 analogs (SRI)SR-13179
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiogenesis inhibitorsApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsProstatic NeoplasmsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSri International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSri International
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A